Braveheart Bio Jumps 68% in Debut After $382.5 Million IPO Backed by A16z
Braveheart Bio (BRAV) stock price soars 68% on IPO day after a $382.5 million offering backed by A16z, signaling strong demand for…
Braveheart Bio (BRAV) stock price soars 68% on IPO day after a $382.5 million offering backed by A16z, signaling strong demand for…
A16z-backed Braveheart seeks $318.8 million in a US IPO, signaling continued vigor in the venture-backed biotech market.
SpaceX's IPO delivers billions in gains to early investors Founders Fund and Andreessen Horowitz, signaling strong returns for space technology backers.
SpaceX's $200 billion IPO is poised to deliver record-breaking returns for venture backers Founders Fund and Andreessen Horowitz, highlighting the booming space…
DraftKings, Meta, and AI firms like Andreessen Horowitz are deploying record cash to influence state election outcomes, aiming to reshape the regulatory…